Prostate Cancer 2b Mortality – The Rates for Patients In the USA

Stating that as many as 27,000 men die from prostate cancer each year in the United States can put fear, but when you compare it in sharp contrast against the number of people who are annually diagnosed with prostate cancer for the first time, between two and three hundred thousand men, you might suddenly realize that perhaps the disease is not so fatal after all.

About 27,000 thousand men dying from prostate cancer every year is by no means a joke ? I mean, that is about 27,000 families in the United States losing a loved one. However one cannot fail to acknowledge the drastic drop in death rates from prostate cancer by comparison to a decade ago when the statistics revealed the numbers to be more than twice this current figure.

So what has changed? More widespread screening, thanks to the American Cancer Society, the National Cancer Institute, the medical community, online and offline educative channels and certainly the men who have taken it to heart that they would do the right thing and get tested no fewer than once a year. Better diagnostic techniques, such the up to 90% of all prostate cancers in the United States today are detected in the early stages. And improved treatments and interventions for the disease, to the end that early stage prostate cancer is not considered to be curable.

Nevertheless, prostate cancer 2b mortality in the United States is still at a figure that most professionals aren’t comfortable with. The reason is glaring though: to start with, even the experts don’t know what the cause of prostate cancer is; and secondly, there really isn’t such a thing as a surefire cure for prostate cancer. These leave many questions unanswered, which have driven several researchers back to the drawing board in search for answers.

What they do have are several risk factors that influence the occurrence of prostate cancer in various regions of the world. For one, even though the reason is not known, prostate cancer is more common in African American men than in Hispanics, Asians, and even Caucasian. It is strange too, considering that the disease is almost nonexistent in non Western (industrialized) countries of the world, whereas the highest incidences of the disease remain in the United States and Europe.

The usual suspects as a result of the obvious are age, genetics, race, diet, lifestyle medications, and a number of other factors that play different roles in the occurrence of the disease. Preventing or curing the condition therefore has to be by manipulating these risk factors in some way, even in spite of whatever medications or treatments are being administered by the oncologist.

No Related Articles.

Speak Your Mind

Tell us what you're thinking... !